Instant International
Written by: Hong Yilin
2021-03-20 21:13
The last update date: 2021-03-20 21:13
Many people in Europe developed blood clots after being injected with the new coronavirus pneumonia (COVID-19) vaccine developed by the British pharmaceutical company AstraZeneca in cooperation with the University of Oxford.
Scientists in Norway and Germany respectively conducted research and claimed on March 18 and 19 respectively that this vaccine may induce the body's own immune response and cause blood clots.
↓If you want to know the lives of people in other places during the epidemic, please click to enlarge and watch:
Scholars at Oslo University Hospital in Norway and Greifswald University Hospital in Germany both believe that the AstraZeneca vaccine triggers an autoimmune response, causing blood to clot in the brain.
AstraZeneca Vaccine|WHO believes that the vaccine is not directly related to blood clots and calls for continued vaccination
AstraZeneca Vaccine | European Medicines Agency emphasizes vaccine safety and will continue to investigate thrombosis
New crown vaccine | AstraZeneca vaccine's thrombosis problem. How do European countries and officials respond?
New Crown Vaccine | Thrombus + Insufficient Supply + Ineffective for Variant AstraZeneca Unfavorable News Frequent
Andreas Greinacher, a professor at Greaves Wald University Hospital in Germany, said at a press conference on the 19th: "Very, very few people will have this kind of complication, but if (this kind of thing) happens, we Now we know how to treat patients."
01News
AstraZeneca Vaccine European Outbreak (New Coronary Pneumonia) New Coronary Pneumonia New Coronary Vaccine Global Outbreak Norway and Germany New Coronary Vaccine Side Effects